These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26611433)

  • 1. Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.
    Liss DT; Finch EA; Gregory DL; Cooper A; Ackermann RT
    Contemp Clin Trials; 2016 Jan; 46():114-121. PubMed ID: 26611433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year effects of a group-based lifestyle intervention in adults with type 2 diabetes: A randomized encouragement trial.
    Liss DT; Finch EA; Cooper A; Sheth A; Tejuosho AD; Lancki N; Ackermann RT
    Diabetes Res Clin Pract; 2018 Jun; 140():36-44. PubMed ID: 29596950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID Study.
    Ackermann RT; Finch EA; Schmidt KK; Hoen HM; Hays LM; Marrero DG; Saha C
    Contemp Clin Trials; 2014 Jan; 37(1):1-9. PubMed ID: 24177413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.
    Eliraqi GM; Vistisen D; Lauritzen T; Sandbaek A; Jørgensen ME; Faerch K
    Diabet Med; 2015 Aug; 32(8):1085-9. PubMed ID: 25819139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and participant characteristics of a primary care adaptation of the Look AHEAD Lifestyle Intervention for weight loss in type 2 diabetes: The REAL HEALTH-diabetes study.
    Delahanty LM; Chang Y; Levy DE; Porneala B; Dushkin A; Bissett L; Goldman V; Perrotta J; Rodriguez AR; Chase B; LaRocca R; Wheeler A; Wexler DJ
    Contemp Clin Trials; 2018 Aug; 71():9-17. PubMed ID: 29803816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.
    Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ
    J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a virtual assistance-based lifestyle intervention in reducing risk factors for Type 2 diabetes in young employees in the information technology industry in India: LIMIT, a randomized controlled trial.
    Limaye T; Kumaran K; Joglekar C; Bhat D; Kulkarni R; Nanivadekar A; Yajnik C
    Diabet Med; 2017 Apr; 34(4):563-568. PubMed ID: 27589695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
    Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Johansen MY; MacDonald CS; Hansen KB; Karstoft K; Christensen R; Pedersen M; Hansen LS; Zacho M; Wedell-Neergaard AS; Nielsen ST; Iepsen UW; Langberg H; Vaag AA; Pedersen BK; Ried-Larsen M
    JAMA; 2017 Aug; 318(7):637-646. PubMed ID: 28810024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: A cluster randomized trial to evaluate "Lifestyle Africa" in South Africa.
    Catley D; Puoane T; Tsolekile L; Resnicow K; Fleming KK; Hurley EA; Smyth JM; Materia FT; Lambert EV; Vitolins MZ; Levitt NS; Goggin K
    PLoS Med; 2022 Apr; 19(4):e1003964. PubMed ID: 35427357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability: An Ancillary Study of the Look AHEAD Study.
    Huckfeldt PJ; Frenier C; Pajewski NM; Espeland M; Peters A; Casanova R; Pi-Sunyer X; Cheskin L; Goldman DP
    JAMA Netw Open; 2020 Nov; 3(11):e2025488. PubMed ID: 33231638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.
    Redmon JB; Bertoni AG; Connelly S; Feeney PA; Glasser SP; Glick H; Greenway F; Hesson LA; Lawlor MS; Montez M; Montgomery B;
    Diabetes Care; 2010 Jun; 33(6):1153-8. PubMed ID: 20332353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors.
    Katula JA; Kirk JK; Pedley CF; Savoca MR; Effoe VS; Bell RA; Bertoni AG;
    Contemp Clin Trials; 2017 Feb; 53():89-99. PubMed ID: 27940180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.
    de Vries TI; Dorresteijn JAN; van der Graaf Y; Visseren FLJ; Westerink J
    Diabetes Care; 2019 Oct; 42(10):1988-1994. PubMed ID: 31416897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.